Azərbaycan Respublikası Elm və Təhsil Nazirliyi
Riyaziyyat və Mexanika İnstitutu
15 research works have been done in the fields of “Frame theory and its applications” and “Spectral properties of non-self-adjoint differential operators” by the employees of the Department of Non-Harmonic Analysis (DNHA) in 2017. There are 22 employees in DNHA, including 1 Doctor of Sciences, 12 PhD’s (5 of them being part-timers), 2 researchers, and […]
27/12/2017
The credibility and relevance of the states at the current stage of the development of the world economy in many respects is define by the technological potential of the country, claiming the rightful place in a tough competitive industrial, scientific and technological world. It is gratifying that our country in this challenging geopolitical and economic […]
27/12/2017
During the reporting period, the International Relations Department carried out its activities in accordance with the scientific and scientific-organizational topics of the Institute of Mathematics and Mechanics and the Department of International Relations of the National Academy of Sciences of Azerbaijan. Within the framework of international events of the Azerbaijan National Academy of Sciences, the […]
26/12/2017
The “School of Young Mathematicians”, organized for the secondary school students within the framework of the “Science and Education Integration” program at the Institute of Mathematics and Mechanics of ANAS, continues its activities. Lessons are conducted in two age groups. Courses of low age (for VI-VII classes) are held at secondary school No 53 in […]
26/12/2017
Taking into account paragraph 32 of Article 109 of the Constitution of the Republic of Azerbaijan, in order to ensure the implementation of the Law of the Republic of Azerbaijan “On the State Budget of the Republic of Azerbaijan for 2018” in connection with 903-VQ order dated December 1, 2017, I decide: 1. in accordance […]
26/12/2017
The FDA has approved a new gene therapy that proves the technique can also be used to treat a variety of diseases other than cancer. According to the agency’s announcement, the therapy called Luxturna can treat biallelic RPE65 mutation-associated retinal dystrophy, a rare eye disease that leads to blindness, in both adults and children. This […]
